Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retrospective Registry of Thai Patients with Type 2 Diabetes Mellitus on SGLT2 Inhibitor Therapy
TCTR20180820003Phase 4Recruiting
- Sponsor
- AstraZeneca
- Start
- Sep 2018
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial in type 2 diabetes mellitus (T2DM), sponsored by AstraZeneca. Started Sep 2018; status: recruiting.
02
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on TCTR20180820003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180820003.